Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jean-Pierre Bleuse"'
Autor:
Marion Carayol, Gregory Ninot, Pierre Senesse, Jean-Pierre Bleuse, Sophie Gourgou, Hélène Sancho-Garnier, Chakib Sari, Isabelle Romieu, Gilles Romieu, William Jacot
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-20 (2019)
Abstract Background Patients with breast cancer undergoing chemotherapy and radiotherapy experience fatigue and other treatment side effects. Integrative therapies combining physical activity and dietary counseling are recommended; however to date no
Externí odkaz:
https://doaj.org/article/d071c60bc9cc47f8b7ac4fba4dcabd84
Autor:
Antoine Adenis, François Ghiringhelli, Ludovic Gauthier, Thibault Mazard, Ludovic Evesque, Pierre-Luc Etienne, Alexandre Evrard, Patrick Chalbos, Jean-Pierre Bleuse, Diego Tosi, Sophie Gourgou, Marc Ychou
Publikováno v:
Journal of Clinical Oncology. 40:3561-3561
3561 Background: Standard treatment options for RAS-mutated mCRC pts include the combination of bevacizumab with FOLFIRINOX, a three-drug chemotherapy regimen. Unlike bevacizumab, REGO – an oral multi-tyrosine kinase agent - exhibits not only antia
Autor:
Sophie Gourgou, Véronique D'Hondt, Marta Jarlier, Ahmed Azzedine, Sophie Sadot-Lebouvier, Laurence Vanlemmens, C. Janiszewski, Géraldine Lauridant, Marion Carayol, Sébastien Mas, Philippe Dalivoust, Pierre Senesse, Jean-Pierre Bleuse, J. Grenier, Antoine Arnaud, William Jacot, C. Lefeuvre-Plesse, Grégory Ninot, Silene Launay, Olivier Tredan, Gilles Romieu
Publikováno v:
Nutrients
Nutrients, MDPI, 2020, 12 (10), pp.3081. ⟨10.3390/nu12103081⟩
Nutrients, Vol 12, Iss 3081, p 3081 (2020)
Volume 12
Issue 10
Nutrients, MDPI, 2020, 12 (10), pp.3081. ⟨10.3390/nu12103081⟩
Nutrients, Vol 12, Iss 3081, p 3081 (2020)
Volume 12
Issue 10
Supervised exercise dietary programs are recommended to relieve cancer-related fatigue and weight increase induced by adjuvant treatment of early breast cancer (EBC). As this recommendation lacks a high level of evidence, we designed a multicenter ra
Autor:
Jean-Pierre Bleuse, Joelle Simony-Lafontaine, Emeline Landas, Alexandre Ho-Pun-Cheung, André Pèlegrin, Evelyne Lopez-Crapez, Gérard Mathis, William Jacot, Florence Boissière-Michot, Jean-François Prost, Caroline Mollevi, Hervé Bazin, Thierry Chardès
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2020, 122 (3), pp.397-404. ⟨10.1038/s41416-019-0670-8⟩
British Journal of Cancer, Cancer Research UK, 2020, 122 (3), pp.397-404. ⟨10.1038/s41416-019-0670-8⟩
BackgroundTriple-negative breast cancer (TNBC) has a worse prognosis compared with other breast cancer subtypes, and biomarkers to identify patients at high risk of recurrence are needed. Here, we investigated the expression of human epidermal recept
Autor:
Jacques Dubourdieu, Julien Fraisse, Philippe Cuvillon, Hélène de Forges, Chloé Janiszewski, Sophie Rey Dit Guzer, Gilles Leclerc, Marta Jarlier, Marian Gutowski, Camille Pouliquen, Jean-Pierre Bleuse, Jibba Amraoui, Jésus Diaz
Publikováno v:
JAMA Network Open
Key Points Question What is the benefit of a short hypnosis session before general anesthesia on postoperative outcomes (pain, nausea/vomiting, fatigue, comfort/well-being, anxiety, postanesthesia care unit length of stay, and patient satisfaction) i
Autor:
Sophie Gourgou, Chakib Sari, Grégory Ninot, Marion Carayol, Isabelle Romieu, William Jacot, Gilles Romieu, Pierre Senesse, Jean Pierre Bleuse, Hélène Sancho-Garnier
Publikováno v:
BMC Cancer
BMC Cancer, 2019, 19 (1), pp.737. ⟨10.1186/s12885-019-5896-6⟩
BMC Cancer, BioMed Central, 2019, 19 (1), pp.737. ⟨10.1186/s12885-019-5896-6⟩
BMC Cancer, Vol 19, Iss 1, Pp 1-20 (2019)
BMC Cancer, 2019, 19 (1), pp.737. ⟨10.1186/s12885-019-5896-6⟩
BMC Cancer, BioMed Central, 2019, 19 (1), pp.737. ⟨10.1186/s12885-019-5896-6⟩
BMC Cancer, Vol 19, Iss 1, Pp 1-20 (2019)
Background Patients with breast cancer undergoing chemotherapy and radiotherapy experience fatigue and other treatment side effects. Integrative therapies combining physical activity and dietary counseling are recommended; however to date no large ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e432bfe6e75f93628bf55c5cee26141
https://www.hal.inserm.fr/inserm-02297744
https://www.hal.inserm.fr/inserm-02297744
Autor:
Simone Mirr, L. Roca, Pierre-Jean Lamy, Anna Durigova, Jean-Pierre Bleuse, Sophie Gallet, Gilles Romieu, Delphine Topart, Stéphane Pouderoux, Nelly Firmin, William Jacot
Publikováno v:
Cancer Research. 75:P5-21
Purpose: Only a minority of patients with early breast cancer (EBC) treated with adjuvant or neoadjuvant chemotherapy have sufficient baseline vitamin D. The current recommendations regarding daily vitamin D supplementation appears too low to correct
Autor:
P. Boisselier, D. Delample, A. Falliere, Jean-Pierre Bleuse, P. Roussel, Simon Thezenas, A. Serre, Pierre Senesse, S. Jacquot, J.-M. Levecq, C. Janiszewski
Publikováno v:
Nutrition Clinique et Métabolisme. 32:239-240
Introduction et but de l’etude Les consequences secondaires a la radiochimiotherapie curative dans les cancers des VADS sont d’ordre physique et psychosocial, incluant une diminution de la tolerance a l’effort et de la qualite de vie. Le patien
Autor:
Grégory Ninot, Hélène Sancho-Garnier, Sophie Gourgou-Bourgade, Jean-Pierre Bleuse, Pierre Senesse, Silene Launay, Florence Cousson-Gélie, Marion Carayol, C. Janiszewski, Gilles Romieu, Chakib Sari, William Jacot
Publikováno v:
Contemporary Clinical Trials. 36:531-543
Exercise practice and appropriate nutrition have been advanced as non pharmacological supportive care to reduce side effects related to cancer and its treatment, but large sample-sized randomized controlled trials are needed to confirm such results.
Autor:
Anna Durigova, L. Roca, Nelly Firmin, Pierre-Jean Lamy, William Jacot, Véronique D'Hondt, S. Gallet, Stéphane Pouderoux, L. Abach, Jean-Pierre Bleuse, Gilles Romieu, Delphine Topart, S. Mirr
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (7), pp.1235-1241. ⟨10.1093/annonc/mdw145⟩
Annals of Oncology, Elsevier, 2016, 27 (7), pp.1235-1241. ⟨10.1093/annonc/mdw145⟩
Background A minority of early breast cancer (EBC) patients treated with adjuvant or neoadjuvant chemotherapy have sufficient baseline vitamin D (vitD) level. This randomized phase III study assessed the safety and efficacy of a tailored, high-dose,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9818825507d838c4947caab8c9a480e8
https://hal.umontpellier.fr/hal-02296725
https://hal.umontpellier.fr/hal-02296725